thanks for the post Patient. looks like you have some decent experience investing in health and devices, but I'm wondering - what's the point in mentioning your lack of success in device manufacturers? This has nothing to do with the viability of IMR.
it should come down to whether you believe the tech is good enough to generate revenue post-pandemic and if the expansion roadmap is realistic.
my understanding is that the fundamentals of the investment thesis remain the same, apart from the tech being a little more capital intensive than first thought. the tech is still a game changer, no one else is doing it and it is scaleable.
the delta wave of this pandemic is coming to an end, vaccination rates are up. it may well be lights out if another variant hits, but if that is the case, we will all have more to worry about that just IMR going bust.
IMR Price at posting:
$1.15 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)